» Articles » PMID: 27903255

Epigenetic Evidence for Involvement of the Oxytocin Receptor Gene in Obsessive-compulsive Disorder

Abstract

Background: Obsessive-compulsive disorder (OCD) is a chronic neurodevelopmental disorder that affects up to 3% of the general population. Although epigenetic mechanisms play a role in neurodevelopment disorders, epigenetic pathways associated with OCD have rarely been investigated. Oxytocin is a neuropeptide involved in neurobehavioral functions. Oxytocin has been shown to be associated with the regulation of complex socio-cognitive processes such as attachment, social exploration, and social recognition, as well as anxiety and other stress-related behaviors. Oxytocin has also been linked to the pathophysiology of OCD, albeit inconsistently. The aim of this study was to investigate methylation in two targets sequences located in the exon III of the oxytocin receptor gene (OXTR), in OCD patients and healthy controls. We used bisulfite sequencing to quantify DNA methylation in peripheral blood samples collected from 42 OCD patients and 31 healthy controls.

Results: We found that the level of methylation of the cytosine-phosphate-guanine sites in two targets sequences analyzed was greater in the OCD patients than in the controls. The higher methylation in the OCD patients correlated with OCD severity. We measured DNA methylation in the peripheral blood, which prevented us from drawing any conclusions about processes in the central nervous system.

Conclusion: To our knowledge, this is the first study investigating DNA methylation of the OXTR in OCD. Further studies are needed to evaluate the roles that DNA methylation and oxytocin play in OCD.

Citing Articles

The impact of the early environment on oxytocin receptor epigenetics and potential therapeutic implications.

Nance M, Sullivan K, Puglia M Pediatr Res. 2024; .

PMID: 39548294 DOI: 10.1038/s41390-024-03563-z.


Mild internet use is associated with epigenetic alterations of key neurotransmission genes in salivary DNA of young university students.

Annunzi E, Cannito L, Bellia F, Mercante F, Vismara M, Benatti B Sci Rep. 2023; 13(1):22192.

PMID: 38092954 PMC: 10719329. DOI: 10.1038/s41598-023-49492-5.


Use of Post-mortem Brain Tissue in Investigations of Obsessive- Compulsive Disorder: A Systematic Review.

Lochner C, Naude P, Stein D Curr Neuropharmacol. 2023; 22(5):963-975.

PMID: 37644747 PMC: 10845092. DOI: 10.2174/1570159X21666230829145425.


Microbial Reprogramming in Obsessive-Compulsive Disorders: A Review of Gut-Brain Communication and Emerging Evidence.

Bendriss G, MacDonald R, McVeigh C Int J Mol Sci. 2023; 24(15).

PMID: 37569349 PMC: 10419219. DOI: 10.3390/ijms241511978.


Epigenetics in psychiatry: Beyond DNA methylation.

Kouter K, Salamon Arcan I, Videtic Paska A World J Psychiatry. 2023; 13(6):319-330.

PMID: 37383287 PMC: 10294132. DOI: 10.5498/wjp.v13.i6.319.


References
1.
den Boer J, Westenberg H . Oxytocin in obsessive compulsive disorder. Peptides. 1992; 13(6):1083-5. DOI: 10.1016/0196-9781(92)90010-z. View

2.
Stewart S, Yu D, Scharf J, Neale B, Fagerness J, Mathews C . Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry. 2012; 18(7):788-98. PMC: 4218751. DOI: 10.1038/mp.2012.85. View

3.
Swedo S, Leonard H, Kruesi M, Rettew D, Listwak S, Berrettini W . Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992; 49(1):29-36. DOI: 10.1001/archpsyc.1992.01820010029004. View

4.
Malhotra D, Sebat J . CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012; 148(6):1223-41. PMC: 3351385. DOI: 10.1016/j.cell.2012.02.039. View

5.
Shavitt R, de Mathis M, Oki F, Ferrao Y, Fontenelle L, Torres A . Phenomenology of OCD: lessons from a large multicenter study and implications for ICD-11. J Psychiatr Res. 2014; 57:141-8. PMC: 7326117. DOI: 10.1016/j.jpsychires.2014.06.010. View